Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-178-4 | CAS number: 79-11-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Specific investigations: other studies
Administrative data
- Endpoint:
- specific investigations: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No GLP study, no guideline available.
Data source
Reference
- Reference Type:
- publication
- Title:
- Species and strain sensitivity to the Induction of peroxisome proliferation by chloroacetic acids
- Author:
- DeAngelo AB et al
- Year:
- 1 989
- Bibliographic source:
- Toxicol. Appl. Pharmacol. 101, 285-298
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Species and strain sensitivity to the induction of peroxisome proliferation was investigated. B6C3F1 mice and Sprague-Dawley rats were provided drinking water containing 6-31 mM (1-5 g/L) trichloroacetic acid (TCA), 8-39 mM (1-5 g/L) dichloroacetic acid (DCA), or 11-32 mM (1-3 g/L) monochloroacetic acid (MCA) for 14 days. Thereafter, animals were killed by CO2 asphyxiation.
- GLP compliance:
- not specified
- Type of method:
- in vivo
Test material
- Reference substance name:
- Chloroacetic acid
- EC Number:
- 201-178-4
- EC Name:
- Chloroacetic acid
- Cas Number:
- 79-11-8
- Molecular formula:
- C2H3ClO2
- IUPAC Name:
- chloroacetic acid
- Details on test material:
- Purchased from Aldrich Chemical Co., Inc. (Milwaukee, WI) (purity ≥ 99%). No further details specified.
Constituent 1
Test animals
- Species:
- other: rat and mouse
- Strain:
- other: Rats: Sprague Dawley. Mice: B6C3F1
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Rats (weighing 225-275 g) and mice (weighing 20-25 g) were purchased from Charles River Laboratories (Portage, MI). The animals were maintained on Purina Laboratory Chow and water ad libitum at 22 ± 2°C and 40-60% humidity under a 12-hr light-
Administration / exposure
- Route of administration:
- oral: drinking water
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- Duration: 14 Days
The calculated average daily intakes in mg/kg bw/day for the B6C3F1 mouse over a 14-day period were:
265, 386, and 482 for drinking water containing 11, 21, and 32 mM MCA;
90,166, and 346 for 8, 16, and 39 mM DCA; and
131, 261, and 442 for 6, 12, and 31 mM TCA.
For the Sprague-Dawley rat the 14-day average daily intakes were:
170, 321, and 501 for 11, 21, and 32 mM MCA;
166, 294, and 666 for 8, 16, and 39 mM DCA; and
212, 327, and 719 for 6, 12, and 31 mM TCA. - Frequency of treatment:
- Ad libitum
- Post exposure period:
- Not applicable.
Doses / concentrations
- Remarks:
- basis: nominal in water
Substances were dissolved in distilled water at concentrations 6-31 mM (1-5 g/L) trichloroacetic acid (TCA), 8-39 mM (1-5 g/L) dichloroacetic acid (DCA), or 11-32 mM (1-3 g/L) monochloroacetic acid (MCA), and the pH was adjusted to 6.8-7.2
- No. of animals per sex per dose:
- Not specified.
- Control animals:
- other: Control animals were given drinking water containing 34 mM sodium chloride.
Examinations
- Examinations:
- Body and liver liver weights; hepatic peroxisome proliferation by (I) palmitoyl-CoA oxidase and carnitine acetyl transferase activities, (2) appearance of a peroxisomeproliferation-associated protein, and (3) morphometric analysis of electron micrographs.
- Positive control:
- Not included.
Results and discussion
- Details on results:
- TCA and DCA, but not MCA, increased the mouse relative liver weight in a dose-dependent manner. Rat liver weights were not altered by TCA or DCA treatment, but were depressed by MCA. Hepatic peroxisome proliferation was demonstrated by (I) increased palmitoyl-CoA oxidase and carnitine acetyl transferase activities, (2) appearance of a peroxisome proliferation-associated protein, and (3) morphometric analysis of electron micrographs.
Mouse peroxisome proliferation was enhanced in a dose-dependent manner by both TCA and DCA, but only the high DCA concentration (39 mM) increased rat liver peroxisome proliferation. MCA was ineffective in both species.
Any other information on results incl. tables
Three other mouse strains (Swiss-Webster, C3H, and C57BL/6) and two strains of rat (F344 and Osborne-Mendel) were examined for sensitivity to TCA. TCA (12 and 31 mM) effectively enhanced peroxisome proliferation in all mouse strains, especially the C57BL/6. A more modest enhancement in the Osborne-Mendel (288%) and F344 rat (167%) was seen. Dosing F344 rats with 200 mg/kg TCA in water or com oil for 10 days increased peroxisome proliferation 179 and 278%, respectively, above the vehicle controls. Three other mouse strains (Swiss-Webster, C3H, and C57BL/6) and two strains of rat (F344 and Osborne-Mendel) were examined for sensitivity to TCA. TCA (12 and 31 mM) effectively enhanced peroxisome proliferation in all mouse strains, especially the C57BL/6. A more modest enhancement in the Osborne-Mendel (288%) and F344 rat (167%) was seen. Dosing F344 rats with 200 mg/kg TCA in water or com oil for 10 days increased peroxisome proliferation 179 and 278%, respectively, above the vehicle controls.
Applicant's summary and conclusion
- Conclusions:
- In a 14-D study, Sprague Dawley rats and B6C3F1 mice were exposed via drinking water to three types of acetic acids.
TCA and DCA, but not MCA, increased the mouse relative liver weight in a dose-dependent manner. Rat liver weights were not altered by TCA or DCA treatment, but were depressed by MCA. Hepatic peroxisome proliferation was demonstrated by by both TCA and DCA by (I) increased palmitoyl-CoA oxidase and carnitine acetyl transferase activities, (2) appearance of a peroxisome proliferation-associated protein, and (3) morphometric analysis of electron micrographs. Mouse peroxisome proliferation was enhanced in a dose-dependent manner by both TCA and DCA, but only the high DCA concentration (39 mM) increased rat liver peroxisome proliferation.
This study demonstrates that the mouse is more sensitive than the rat with respect to the enhancement of liver peroxisome proliferation by TCA and DCA and suggest that if peroxisome proliferation is critical for the induction of hepatic cancer by TCA and DCA, then the rat should be less sensitive or refractory to tumor induction. MCA was ineffective in both species.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.